Merck Quarterly Financial Report Q1_2011 - Merck shares (optimized for printing)

The Merck share price rose 6.4% during the first quarter, from EUR 59.85 on December 30, 2010, to EUR 63.68 on March 31, 2011. The share price high during the first quarter was EUR 66.47, recorded on March 11. The low price for the quarter was EUR 59.78 on January 17. Germany’s DAX Index, of which Merck is a member, rose 1.8% during the first quarter and the Bloomberg Europe Pharmaceuticals Index rose 1.2%.

Share data¹

XLS

Q1 – 2011

Year 2010

1	Share-price relevant figures relate to the closing price in XETRA trading on the Frankfurt Stock Exchange.
2	The calculation of the theoretical number of shares is based on the fact that the general partner‘s equity capital is not represented by shares. As the share capital of EUR 168.0 million was divided into 64.6 million shares, the corresponding calculation resulted in 152.8 million theoretical shares for the general partner’s capital of EUR 397.2 million on the balance sheet date March 31, 2011.
3	Based on the theoretical number of shares as of March 31, 2011.

Share price high in EUR

(March 11) 66.47

(Sep. 10) 72.28

Share price low in EUR

(Jan. 17) 59.78

(Feb. 25) 57.62

Closing share price in EUR

(March 31) 63.68

(Dec. 30) 59.85

Actual number of shares in millions

64.6

Theoretical number² of shares in millions

217.4

Market capitalization³ in EUR million

13,843

13,011

Merck shares

The performance of Merck shares vs. the DAX ®/Bloomberg Europe Pharmaceuticals Index